Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Insomnia Pharmacological Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insomnia Pharmacological Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Insomnia Pharmacological Treatment Overall Market Size
2.1 Global Insomnia Pharmacological Treatment Market Size: 2021 VS 2028
2.2 Global Insomnia Pharmacological Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Insomnia Pharmacological Treatment Players in Global Market
3.2 Top Global Insomnia Pharmacological Treatment Companies Ranked by Revenue
3.3 Global Insomnia Pharmacological Treatment Revenue by Companies
3.4 Top 3 and Top 5 Insomnia Pharmacological Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Insomnia Pharmacological Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Insomnia Pharmacological Treatment Players in Global Market
3.6.1 List of Global Tier 1 Insomnia Pharmacological Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Insomnia Pharmacological Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Insomnia Pharmacological Treatment Market Size Markets, 2021 & 2028
4.1.2 Prescription Sleep Aids
4.1.3 Over-the-Counter Sleep Aids
4.2 By Type - Global Insomnia Pharmacological Treatment Revenue & Forecasts
4.2.1 By Type - Global Insomnia Pharmacological Treatment Revenue, 2017-2022
4.2.2 By Type - Global Insomnia Pharmacological Treatment Revenue, 2023-2028
4.2.3 By Type - Global Insomnia Pharmacological Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Insomnia Pharmacological Treatment Market Size, 2021 & 2028
5.1.2 Homecare
5.1.3 Clinic
5.1.4 Hospital
5.2 By Application - Global Insomnia Pharmacological Treatment Revenue & Forecasts
5.2.1 By Application - Global Insomnia Pharmacological Treatment Revenue, 2017-2022
5.2.2 By Application - Global Insomnia Pharmacological Treatment Revenue, 2023-2028
5.2.3 By Application - Global Insomnia Pharmacological Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Insomnia Pharmacological Treatment Market Size, 2021 & 2028
6.2 By Region - Global Insomnia Pharmacological Treatment Revenue & Forecasts
6.2.1 By Region - Global Insomnia Pharmacological Treatment Revenue, 2017-2022
6.2.2 By Region - Global Insomnia Pharmacological Treatment Revenue, 2023-2028
6.2.3 By Region - Global Insomnia Pharmacological Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Insomnia Pharmacological Treatment Revenue, 2017-2028
6.3.2 US Insomnia Pharmacological Treatment Market Size, 2017-2028
6.3.3 Canada Insomnia Pharmacological Treatment Market Size, 2017-2028
6.3.4 Mexico Insomnia Pharmacological Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Insomnia Pharmacological Treatment Revenue, 2017-2028
6.4.2 Germany Insomnia Pharmacological Treatment Market Size, 2017-2028
6.4.3 France Insomnia Pharmacological Treatment Market Size, 2017-2028
6.4.4 U.K. Insomnia Pharmacological Treatment Market Size, 2017-2028
6.4.5 Italy Insomnia Pharmacological Treatment Market Size, 2017-2028
6.4.6 Russia Insomnia Pharmacological Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Insomnia Pharmacological Treatment Market Size, 2017-2028
6.4.8 Benelux Insomnia Pharmacological Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Insomnia Pharmacological Treatment Revenue, 2017-2028
6.5.2 China Insomnia Pharmacological Treatment Market Size, 2017-2028
6.5.3 Japan Insomnia Pharmacological Treatment Market Size, 2017-2028
6.5.4 South Korea Insomnia Pharmacological Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Insomnia Pharmacological Treatment Market Size, 2017-2028
6.5.6 India Insomnia Pharmacological Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Insomnia Pharmacological Treatment Revenue, 2017-2028
6.6.2 Brazil Insomnia Pharmacological Treatment Market Size, 2017-2028
6.6.3 Argentina Insomnia Pharmacological Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Insomnia Pharmacological Treatment Revenue, 2017-2028
6.7.2 Turkey Insomnia Pharmacological Treatment Market Size, 2017-2028
6.7.3 Israel Insomnia Pharmacological Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Insomnia Pharmacological Treatment Market Size, 2017-2028
6.7.5 UAE Insomnia Pharmacological Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Eisai, Co. Ltd. (Japan)
7.1.1 Eisai, Co. Ltd. (Japan) Corporate Summary
7.1.2 Eisai, Co. Ltd. (Japan) Business Overview
7.1.3 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Major Product Offerings
7.1.4 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.1.5 Eisai, Co. Ltd. (Japan) Key News
7.2 Merck & Co., Inc (US)
7.2.1 Merck & Co., Inc (US) Corporate Summary
7.2.2 Merck & Co., Inc (US) Business Overview
7.2.3 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Major Product Offerings
7.2.4 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.2.5 Merck & Co., Inc (US) Key News
7.3 Meda Consumer Healthcare Inc (US)
7.3.1 Meda Consumer Healthcare Inc (US) Corporate Summary
7.3.2 Meda Consumer Healthcare Inc (US) Business Overview
7.3.3 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Major Product Offerings
7.3.4 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.3.5 Meda Consumer Healthcare Inc (US) Key News
7.4 Pfizer, Inc (US)
7.4.1 Pfizer, Inc (US) Corporate Summary
7.4.2 Pfizer, Inc (US) Business Overview
7.4.3 Pfizer, Inc (US) Insomnia Pharmacological Treatment Major Product Offerings
7.4.4 Pfizer, Inc (US) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.4.5 Pfizer, Inc (US) Key News
7.5 Sanofi (France)
7.5.1 Sanofi (France) Corporate Summary
7.5.2 Sanofi (France) Business Overview
7.5.3 Sanofi (France) Insomnia Pharmacological Treatment Major Product Offerings
7.5.4 Sanofi (France) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.5.5 Sanofi (France) Key News
7.6 Takeda Pharmaceutical Company Ltd. (Japan)
7.6.1 Takeda Pharmaceutical Company Ltd. (Japan) Corporate Summary
7.6.2 Takeda Pharmaceutical Company Ltd. (Japan) Business Overview
7.6.3 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Major Product Offerings
7.6.4 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.6.5 Takeda Pharmaceutical Company Ltd. (Japan) Key News
7.7 Pernix Therapeutics (US)
7.7.1 Pernix Therapeutics (US) Corporate Summary
7.7.2 Pernix Therapeutics (US) Business Overview
7.7.3 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Major Product Offerings
7.7.4 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.7.5 Pernix Therapeutics (US) Key News
7.8 Purdue Pharma L.P (US)
7.8.1 Purdue Pharma L.P (US) Corporate Summary
7.8.2 Purdue Pharma L.P (US) Business Overview
7.8.3 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Major Product Offerings
7.8.4 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Revenue in Global Market (2017-2022)
7.8.5 Purdue Pharma L.P (US) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer